$95.17 -1.05 (%) Johnson & Johnson - NYSE

Aug. 28, 2015 | 04:00 PM

Partner Headlines

  1. Five High-Quality Dividend Growth Stocks That Look Very Appealing After Recent Volatility

    GuruFocus | Aug. 27, 2015 | 19:38PM EST
  2. Benzinga's M&A Chatter for Tuesday, August 25, 2015

    Benzinga | Aug. 25, 2015 | 19:08PM EST
  3. AptarGroup: The Leader in Dispensing Innovation

    GuruFocus | Aug. 21, 2015 | 15:31PM EST
  4. Valeant Pharmaceuticals' New Female Drug

    GuruFocus | Aug. 20, 2015 | 12:47PM EST
  5. Dividend Investors Should Consider Johnson & Johnson

    GuruFocus | Aug. 19, 2015 | 18:36PM EST
  6. JNJ - Should It Be In Your Portfolio?

    GuruFocus | Aug. 19, 2015 | 12:13PM EST
  7. AbbVie: The Riskiest Dividend Aristocrat

    GuruFocus | Aug. 18, 2015 | 12:37PM EST
  8. S&P 500 Index Futures Trading Lower

    Benzinga | Aug. 18, 2015 | 10:43AM EST
  9. Long-Term Study: Relative Historical Yield & High Quality Businesses

    GuruFocus | Aug. 15, 2015 | 09:32AM EST
  10. When Size Matters, Consider These ETFs

    Benzinga | Aug. 13, 2015 | 07:29AM EST
  11. Johnson & Johnson Cashes Out Of Aquinox Pharmaceuticals' Parabolic Rally

    Benzinga | Aug. 12, 2015 | 13:35PM EST
  12. 20 Dividend Growth Stocks to Buy Today for Your Retirement Portfolios: Part 1

    GuruFocus | Aug. 7, 2015 | 19:04PM EST
  13. Johnson & Johnson

    IBD | Aug. 7, 2015 | 18:45PM EST
  14. Johnson & Johnson: 53 Years of Low-Risk Dividend Growth

    GuruFocus | Aug. 6, 2015 | 12:36PM EST
  15. 5 U.S. Mega Caps With Less Than 0.1% Insider Ownership

    Benzinga | Aug. 4, 2015 | 11:15AM EST
  16. A Short Story of Questionable Capital Allocation

    GuruFocus | Aug. 3, 2015 | 12:32PM EST
  17. Achillion Announces Janssen Initiated Phase I Study to Evaluate Effect of Simeprevir and Odalasvir on AL-335 Pharmacokinetics

    Benzinga | Aug. 3, 2015 | 04:20AM EST
  18. Valeant Missed Out On Botox But Hits With Other Buys

    IBD | Jul. 31, 2015 | 16:03PM EST
  19. Retired Investors Don't Buy Bonds Until?

    GuruFocus | Jul. 29, 2015 | 13:43PM EST
  20. NuVasive Hits 7-Year High After Q2 Earnings Beat

    IBD | Jul. 29, 2015 | 11:04AM EST
  21. S&P 500 Index Futures Trading Higher

    Benzinga | Jul. 29, 2015 | 10:26AM EST
  22. Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

    IBD | Jul. 28, 2015 | 16:03PM EST
  23. ETFs For The Next Pharma Takeover Candidates

    Benzinga | Jul. 28, 2015 | 13:08PM EST
  24. Biogen Plunges On Slashed Guidance; AbbVie Q2 Mixed

    IBD | Jul. 24, 2015 | 11:44AM EST
  25. Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles

    IBD | Jul. 21, 2015 | 13:15PM EST
  26. Who Doesn't Like Top Stocks With Big, Steady Payout?

    IBD | Jul. 20, 2015 | 18:05PM EST
  27. Pennsylvania Trust Co.'s Top Sales in Q2 2015

    GuruFocus | Jul. 19, 2015 | 22:47PM EST
  28. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD | Jul. 18, 2015 | 08:02AM EST
  29. Yacktman Fund Reduces Stakes in Six of its Most Valuable Holdings

    GuruFocus | Jul. 15, 2015 | 19:10PM EST
  30. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  31. Johnson & Johnson Profit Dips

    IBD | Jul. 14, 2015 | 18:54PM EST
  32. J&J Earnings Beat Views As Pharma Leads Way Again

    IBD | Jul. 14, 2015 | 11:18AM EST
  33. Stocks Creep Up In Mixed Trade; Micron, GoPro, Ambarella Climb

    IBD | Jul. 14, 2015 | 10:34AM EST
  34. Stock Futures Tightly Mixed; Micron, GoPro, JPMorgan Gain Ground

    IBD | Jul. 14, 2015 | 09:09AM EST
  35. Futures Sag Amid Iran Deal, Earnings, Data

    FoxBusiness | Jul. 14, 2015 | 08:45AM EST
  36. Johnson & Johnson Q2 Earnings Top Expectations

    Benzinga | Jul. 14, 2015 | 08:12AM EST
  37. 7 Stocks You Should Be Watching Today

    Benzinga | Jul. 14, 2015 | 04:14AM EST
  38. Stock Futures Rise On Greek Deal; Anacor, Edwards Lifesciences Rising

    IBD | Jul. 13, 2015 | 09:13AM EST
  39. Designing a Retirement Portfolio That's Just Right For You

    GuruFocus | Jul. 10, 2015 | 15:22PM EST
  40. Strong Dollar? Not So Good For Johnson & Johnson Earnings

    Benzinga | Jul. 10, 2015 | 11:41AM EST
  41. Horizon Makes Unsolicited $3 Billion Bid For Depomed

    IBD | Jul. 7, 2015 | 10:27AM EST
  42. S&P 500 Index Futures Trading Higher

    Benzinga | Jun. 26, 2015 | 11:38AM EST
  43. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD | Jun. 22, 2015 | 13:56PM EST
  44. The Surprising Llink Between Volatility And Returns

    GuruFocus | Jun. 22, 2015 | 13:18PM EST
  45. Follow Bill Ackman in Valeant Pharmaceuticals

    GuruFocus | Jun. 19, 2015 | 12:32PM EST
  46. A 'Gay Friendly' Portfolio Includes Apple, Microsoft & Disney...And It Beats The Market

    Benzinga | Jun. 19, 2015 | 10:53AM EST
  47. Baozun: The Little Guy Behind Big Brands In China

    IBD | Jun. 17, 2015 | 17:59PM EST
  48. An app that tracks the sniffles

    IBD | Jun. 15, 2015 | 18:44PM EST
  49. Johnson & Johnson Looks Attractive

    GuruFocus | Jun. 12, 2015 | 12:41PM EST
  50. IBM Watson Engages Industry With New Era Of Computing

    IBD | Jun. 12, 2015 | 09:34AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!